Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China

[1]  Weili Yan,et al.  Antibiotic Use in Neonatal Intensive Care Units in China: A Multi-center Cohort Study. , 2021, The Journal of pediatrics.

[2]  Chengyuan Zhang,et al.  Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017–2019 , 2021, Antimicrobial Resistance and Infection Control.

[3]  J. Mathias,et al.  Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS) , 2021, The Lancet. Infectious diseases.

[4]  K. Hood,et al.  Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries , 2021, Nature Microbiology.

[5]  V. Mondì,et al.  A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study , 2021, EClinicalMedicine.

[6]  Chengyuan Zhang,et al.  Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017–2019 , 2021, Antimicrobial Resistance & Infection Control.

[7]  Yuan Shi,et al.  Effect of antibiotic-induced intestinal dysbacteriosis on bronchopulmonary dysplasia and related mechanisms , 2021, Journal of Translational Medicine.

[8]  S. Emonet,et al.  [Rapid microbiology and antimicrobial stewardship to combat antibiotic resistance]. , 2020, Revue medicale suisse.

[9]  M. Caserta,et al.  A Quality Improvement Initiative To Optimize Antibiotic Use in a Level 4 NICU , 2020, Pediatrics.

[10]  A. Fanaroff,et al.  Advances in Neonatal Infections , 2020, American Journal of Perinatology.

[11]  M. Zemlin,et al.  Real‐life clinical studies are needed after a quality improvement study in neonatal sepsis showed unexpected improvements , 2020, Acta paediatrica.

[12]  Weili Yan,et al.  Epidemiology and microbiology of late-onset sepsis among preterm infants in China, 2015-2018: A cohort study. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  B. Poindexter,et al.  The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach , 2019, American journal of respiratory and critical care medicine.

[14]  A. A. T. Barbosa,et al.  Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. , 2019, Microbial drug resistance.

[15]  G. Dimitriou,et al.  Antimicrobial Stewardship in the Neonatal Intensive Care Unit: An Update , 2019, Current pediatric reviews.

[16]  H. Osiovich,et al.  Reduction of Inappropriate Antimicrobial Prescriptions in a Tertiary Neonatal Intensive Care Unit After Antimicrobial Stewardship Care Bundle Implementation. , 2019, The Pediatric infectious disease journal.

[17]  Julie M. Herlihy,et al.  Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study , 2019 .

[18]  S. Joshi,et al.  Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal , 2018, BMC Pediatrics.

[19]  E. Jensen,et al.  Association Between Early Antibiotic Exposure and Bronchopulmonary Dysplasia or Death , 2018, Journal of Perinatology.

[20]  Y. Jia,et al.  Risk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China. , 2017, The Journal of hospital infection.

[21]  T. Kawakita,et al.  Antibiotic stewardship in perinatal and neonatal care. , 2017, Seminars in fetal & neonatal medicine.

[22]  P. Sánchez,et al.  Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. , 2016, The Lancet. Infectious diseases.

[23]  A. Tomasz,et al.  Mechanisms of vancomycin resistance in Staphylococcus aureus. , 2014, The Journal of clinical investigation.

[24]  R. Polk,et al.  Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. , 2014, Infectious disease clinics of North America.

[25]  A. Stroustrup,et al.  Antibiotic Use in Newborns with Transient Tachypnea of the Newborn , 2013, Neonatology.

[26]  Johannes B. Reitsma,et al.  Clinical signs to identify late-onset sepsis in preterm infants , 2013, European Journal of Pediatrics.

[27]  B. Stoll,et al.  Prolonged Duration of Initial Empirical Antibiotic Treatment Is Associated With Increased Rates of Necrotizing Enterocolitis and Death for Extremely Low Birth Weight Infants , 2009, Pediatrics.

[28]  J Thomson,et al.  Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources , 2006 .

[29]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.